SRH Advisors’s Celgene Corp CELG Stock Holding History

SRH Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20	Closed	-$2K	–	271
2019 Q3	$2K	Hold	20	–	–	0.01%	259
2019 Q2	$2K	Hold	20	–	–	0.01%	265
2019 Q1	$2K	Hold	20	–	–	0.01%	257
2018 Q4	$1K	Hold	20	–	–	﹤0.01%	265
2018 Q3	$2K	Hold	20	–	–	0.01%	281
2018 Q2	$2K	Hold	20	–	–	0.01%	266
2018 Q1	$2K	Hold	20	–	–	0.01%	232
2017 Q4	$2K	Hold	20	–	–	0.01%	224
2017 Q3	$3K	Hold	20	–	–	0.01%	203
2017 Q2	$3K	Hold	20	–	–	0.01%	174
2017 Q1	$2K	Hold	20	–	–	0.01%	205
2016 Q4	$2K	Hold	20	–	–	0.01%	209
2016 Q3	$2K	Hold	20	–	–	0.01%	209
2016 Q2	$2K	Hold	20	–	–	0.01%	205
2016 Q1	$2K	Hold	20	–	–	0.01%	215
2015 Q4	$2K	Hold	20	–	–	0.01%	211
2015 Q3	$2K	Hold	20	–	–	0.01%	218
2015 Q2	$2K	Hold	20	–	–	0.01%	221
2015 Q1	$2K	Hold	20	–	–	0.01%	212
2014 Q4	$2K	Hold	20	–	–	0.01%	214
2014 Q3	$2K	Buy	+20	New	+$1.8K	0.02%	198

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

SRH Advisors's CELG Position: Q4 2019 in Review

SRH Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 20 shares — an estimated $2K sold.

SRH Advisors first reported a position in CELG in Q3 2014 and held it in 21 quarters. The position peaked at $3K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

SRH Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
SRH Advisors sold 20 Celgene Corp shares in Q4 2019, an estimated $2K.
SRH Advisors first reported a position in Celgene Corp in Q3 2014 and held it in 21 quarters.
SRH Advisors's Celgene Corp position peaked at $3K in Q3 2017.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on SRH Advisors's 13F filing for Q4 2019, filed 31 Jan 2020.